Abstract
Liver resection is the only cure-oriented strategy for colorectal liver metastases, even in elderly patients. In the literature, there are no significant differences in overall survival and disease-free survivals between the elderly and the younger patients, who underwent liver resection, immediately or after preoperative chemotherapy. Morbidity and mortality rates are slightly increased in the elderly. Careful preoperative evaluation and postoperative monitoring is essential to improve patients’ survival. Patient selection should be discussed on a case-by-case basis by a multidisciplinary team. Older age is not a contraindication for liver resection.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
• Ferlay J, Shin H-R, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127:2893–917. This article is the latest worldwide cancer statistics by IARC.
CANCER STATISTICS in JAPAN ‘09 Available at http://ganjoho.jp/public/statistics/backnumber/2010_jp.html.
Folprecht G, Gruenberger T, Bechstein BO, et al. Tumor response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: thr CELIM randomised phase 2 trial. Lancet Oncol. 2010;11:38–47.
Falcone A, Ricci S, Brunetti I, et al. Phase III trial of Infusional Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan (FOLFOXIRI) Compared With Infusional Fluorouracil, Leucovorin, and Irinotecan (FOLFIRI) as first-line treatment for metastatic colorectal cancer: the Gruppo Oncologico Nord Ovest. J Clin Oncol. 2007;25:1670–6.
Nordinger B, Sorbye H, Glimelius B, et al. Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial. Lancet. 2008;371:1007–16.
Japanese Society for Cancer of the Colon and Rectum. Japanese classification of colorectal carcinoma, Second English Edition. Tokyo: Kanehara & Co., Ltd; 2009.
Kanemitsu Y, Kato T, Shimizu Y, et al. A randomized phase II/III trial comparing hepatectomy followed by mFOLFOX6 with hepatectomy alone as treatment for liver metastasis from colorectal cancer: Japan Clinical Oncology Group Study JCOG0603. Jpn J Clin Oncol. 2009;39(6):406–9.
Colorectal Cancer Collaborative Group. Surgery for colorectal cancer in elderly patients: a systematic review. Lancet. 2000;356:968–74.
•• Pallis AG, Papamichael D, Audisio R, et al. EORTC Elderly Task Force experts’ opinion for the treatment of colon cancer in older patients. Cancer Treat Rev. 2010;36:83–90. This article is a recent taskforce report of treatments for elderly colorectal cancer patients from the EORTC.
Zacharias T, Jaeck D, Oussoultzoglou E, et al. First and repeat resection of colorectal liver metastases in elderly patients. Ann Surg. 2004;240(5):858–65.
Mazzoni G, Tocchi A, Miccini M, et al. Surgical treatment of liver metastases from colorectal cancer in elderly patients. Int J Colorectal Dis. 2007;22(1):77–83.
Mann CD, Neal CP, Pattenden CJ, et al. Major resection of hepatic colorectal liver metastases in elderly patients – an aggressive approach is justified. Eur J Surg Oncol. 2008;34(4):428–32.
Bockhorn M, Sotiropoulos GC, Sgourakis G, et al. Major liver resections in the elderly—is an aggressive approach justified? Int J Colorectal Dis. 2009;24(1):83–6.
de Liguori-Carino N, van Leeuwen BL, Ghaneh P, et al. Liver resection for colorectal liver metastases in older patients. Crit Rev Oncol Hematol. 2008;67(3):273–8.
Alberts SR, Horvath WL, Sternfeld WC, et al. Oxaliplatin, Fluorouracil, and Leucovorin for Patients With Unresectable Liver-Only Metastases From Colorectal Cancer: A North Central Cancer Treatment Group Phase II Study. J Clin Oncol. 2005;23:9243–9.
Skof E, Rebersek M, Hlebanja Z, et al. Capecitabine plus Irinotecan (XELIRI regimen) compared to 5-FU/LV plus Irinotecan (FOLFIRI regimen) as neoadjuvant treatment for patients with unresectable liver-only metastases of metastatic colorectal cancer: a randomised prospective phase II trial. BMC Cancer. 2009;9:120.
Coskun U, Buyukberber S, Yaman E, et al. Xelox (capecitabine plus oxaliplatin) as neoadjuvant chemotherapy of unresectable liver metastases in colorectal cancer patients. Neoplasma. 2008;55(1):65–70.
Van Cutsem E, Rivera F, Berry S, et al. Safety and efficacy of first-line bevacizumab with FOLFOX, XELOX, FOLFIRI and fluoropyrimidines in metastatic colorectal cancer: the BEAT study. Ann Oncol. 2009;20(11):1842–7.
Min BS, Kim NK, Ahn JB, et al. Cetuximab in combination with 5-fluorouracil, leucovorin and irinotecan as a neoadjuvant chemotherapy in patients with initially unresectable colorectal liver metastases. Onkologie. 2007;30(12):637–43.
Sanoff HK, Bleiberg H, Goldberg RM. Managing older patients with colorectal cancer. J Clin Oncol. 2007;25(14):1891–7.
Disclosure
No potential conflict of interest relevant to this article was reported.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Shimada, Y. Liver Resection for Colorectal Metastases: Is There an Age Limit? The Japanese Perspective. Curr Colorectal Cancer Rep 7, 187–190 (2011). https://doi.org/10.1007/s11888-011-0095-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11888-011-0095-0